Mechanisms of sleep disturbances in Long-Term cancer survivors: a childhood cancer survivor study report.

BACKGROUND: Sleep problems following childhood cancer treatment may persist into adulthood, exacerbating cancer-related late effects and putting survivors at risk for poor physical and psychosocial functioning. This study examines sleep in long-term survivors and their siblings to identify risk factors and disease correlates.

METHODS: Childhood cancer survivors (≥5 years from diagnosis; n = 12,340; 51.5% female; mean[SD] age = 39.4[9.6] years) and siblings (n = 2395; 57.1% female; age = 44.6[10.5] years) participating in the Childhood Cancer Survivor Study completed the Pittsburgh Sleep Quality Index (PSQI). Multivariable Poisson-error generalized estimating equation compared prevalence of binary sleep outcomes between survivors and siblings and evaluated cancer history and chronic health conditions (CHC) for associations with sleep outcomes, adjusting for age (at diagnosis and current), sex, race/ethnicity, and BMI.

RESULTS: Survivors were more likely to report clinically-elevated composite PSQI scores (>5; 45.1% vs 40.0%, adjusted prevalence ratio [PR] 1.20, 95%CI 1.13-1.27), symptoms of insomnia (38.8% vs 32.0%, PR = 1.26, 95%CI 1.18-1.35), snoring (18.0% vs 17.4%, PR = 1.11, 95%CI 1.01-1.23), and sleep medication use (13.2% vs 11.5%, PR = 1.28, 95%CI 1.12-1.45) compared to siblings. Within cancer survivors, PSQI scores were similar across diagnoses. Anthracycline exposure (PR = 1.13, 95%CI 1.03-1.25), abdominal radiation (PR = 1.16 95%CI 1.04-1.29) and increasing CHC burden were associated with elevated PSQI scores (PRs 1.21-1.48).

CONCLUSIONS: Among survivors, sleep problems were more closely related to CHC than diagnosis or treatment history, though longitudinal research is needed to determine the direction of this association. Frequent sleep-promoting medication use suggests interest in managing sleep problems; behavioral sleep intervention is advised for long-term management.